Delcath to Present at Oppenheimer 28th Annual Healthcare Conference
Mar 19, 2018 20:05 pm UTC| Business
NEW YORK, March 19, 2018 -- Delcath Systems, Inc. (OTCQB:DCTH), an interventional oncology Company focused on the treatment of primary and metastatic liver cancers, announces that Jennifer K. Simpson, Ph.D., MSN, CRNP,...
HealthEquity Reports Fourth Quarter and Fiscal Year Ended January 31, 2018 Financial Results
Mar 19, 2018 20:04 pm UTC| Business
Highlights of the fiscal year include: Revenue of $229.5 million, an increase of 29% compared to FY17.Net income of $47.4 million, an increase of 80% compared to FY17.Net income per diluted share of $0.77, compared to...
Avinger Announces Fourth Quarter and Full Year 2017 Results
Mar 19, 2018 20:01 pm UTC| Business
REDWOOD CITY, Calif., March 19, 2018 -- Avinger, Inc. (Nasdaq:AVGR) (“Avinger” or the “Company”), a leading developer of innovative treatments for peripheral artery disease (PAD), today reported results for the fourth...
Mar 19, 2018 20:01 pm UTC| Business
NEW YORK, March 19, 2018 -- New York Mortgage Trust, Inc. (Nasdaq:NYMT) (the “Company”) announced today that its Board of Directors (the “Board”) declared a regular quarterly cash dividend of $0.20 per share on shares...
Cardlytics Announces Fourth Quarter and Full Year 2017 Financial Results
Mar 19, 2018 20:01 pm UTC| Business
ATLANTA, March 19, 2018 -- Cardlytics, Inc., (NASDAQ:CDLX), a purchase intelligence platform that helps make marketing more relevant and measurable, today announced financial results for the fourth quarter and full year...
AIT Therapeutics Reports Year End 2017 Financial Results
Mar 19, 2018 20:01 pm UTC| Business
Expects first regulatory filing for the NO Generator and Delivery System in persistent pulmonary hypertension of the newborn (PPHN) by end of 2018 Closed global, exclusive license for revolutionary NO Generator and...
Molecular Templates to Present at the Oppenheimer 28th Annual Healthcare Conference
Mar 19, 2018 20:01 pm UTC| Business
AUSTIN, Texas, March 19, 2018 -- Molecular Templates, Inc., (Nasdaq:MTEM) a clinical stage biopharmaceutical company focused on the discovery and development of Engineered Toxin Bodies (ETBs), a new class of targeted...
China Signals Subtle Treasury Pullback: Banks Urged to Ease US Debt Exposure
China Signals Quiet Treasury Trim: Banks Told to Ease Up on US Debt
The “Takaichi Trade”: How Japan’s First Female PM Is Shaping the Yen
How the US–India tariff truce boosts major Indian industries, Surat to Pharma